Published : Jul-2017
No. of Pages : 213
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Neurology Devices Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 11
3 Neurology Devices Market, United Kingdom 15
3.1 Neurology Devices Market, United Kingdom, Revenue ($m), 2009-2023 15
3.2 Neurology Devices Market, United Kingdom, Revenue ($m), 2009-2016 17
3.5 Neurology Devices Market, United Kingdom, Revenue ($m), 2016-2023 19
3.6 Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023 21
3.7 Neurology Devices Market, United Kingdom, Volume (Units), 2009-2016 23
3.8 Neurology Devices Market, United Kingdom, Volume (Units), 2016-2023 25
3.9 Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 27
4 CSF Management Market, United Kingdom 29
4.1 CSF Management Market, United Kingdom, Revenue Mix ($m), 2016 29
4.2 CSF Management Market, United Kingdom, Segment Contribution (%), 2016 30
4.3 CSF Management Market, United Kingdom, Revenue ($m), 2009-2016 31
4.4 CSF Management Market, United Kingdom, Revenue ($m), 2016-2023 33
4.5 CSF Management Market, United Kingdom, Volume (Units), 2009-2016 35
4.6 CSF Management Market, United Kingdom, Volume (Units), 2016-2023 37
4.7 CSF Management Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 39
4.8 CSF Management Market, United Kingdom, Company Share by Revenue ($m), 2016 40
5 Interventional Neurology Market, United Kingdom 42
5.1 Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2016 42
5.2 Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016 43
5.3 Interventional Neurology Market, United Kingdom, Revenue ($m), 2009-2016 45
5.4 Interventional Neurology Market, United Kingdom, Revenue ($m), 2016-2023 47
5.4.1 Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), by Segment, 2009-2016 49
5.4.2 Navigational System Market, United Kingdom, Revenue ($m), by Segment, 2009-2016 51
5.4.3 Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), by Segment, 2016-2023 53
5.4.4 Navigational System Market, United Kingdom, Revenue ($m), by Segment, 2016-2023 55
5.5 Interventional Neurology Market, United Kingdom, Volume (Units), 2009-2016 57
5.6 Interventional Neurology Market, United Kingdom, Volume (Units), 2016-2023 59
5.6.1 Embolization and Coiling Devices Market, United Kingdom, Volume (Units), by Segment, 2009-2016 61
5.6.2 Navigational System Market, United Kingdom, Volume (Units), by Segment, 2009-2016 63
5.6.3 Embolization and Coiling Devices Market, United Kingdom, Volume (Units), by Segment, 2016-2023 65
5.6.4 Navigational System Market, United Kingdom, Volume (Units), by Segment, 2016-2023 67
5.7 Interventional Neurology Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 69
5.8 Interventional Neurology Market, United Kingdom, Company Share by Revenue ($m), 2016 70
6 Neurological Diagnostic Equipment Market, United Kingdom 72
6.1 Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2016 72
6.2 Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016 73
6.3 Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), 2009-2016 74
6.4 Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), 2016-2023 76
6.5 Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), 2009-2016 78
6.6 Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), 2016-2023 80
6.7 Neurological Diagnostic Equipment Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 82
6.8 Neurological Diagnostic Equipment Market, United Kingdom, Company Share by Revenue ($m), 2016 83
7 Neurostimulation Devices Market, United Kingdom 85
7.1 Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2016 85
7.2 Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016 86
7.3 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2009-2016 87
7.4 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2016-2023 89
7.5 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2009-2016 91
7.6 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2016-2023 93
7.7 Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 95
7.8 Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 96
8 Neurosurgical Products Market, United Kingdom 98
8.1 Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2016 98
8.2 Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016 99
8.3 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2009-2016 100
8.4 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2016-2023 102
8.5 Neurosurgical Products Market, United Kingdom, Volume (Units), 2009-2016 104
8.6 Neurosurgical Products Market, United Kingdom, Volume (Units), 2016-2023 106
8.7 Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 108
8.8 Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), 2016 109
9 Radiosurgery Market, United Kingdom 111
9.1 Radiosurgery Market, United Kingdom, Revenue ($m), 2009-2016 111
9.2 Radiosurgery Market, United Kingdom, Revenue ($m), 2016-2023 113
9.3 Radiosurgery Market, United Kingdom, Volume (Units), 2009-2016 115
9.4 Radiosurgery Market, United Kingdom, Volume (Units), 2016-2023 117
10 Overview of Key Companies in United Kingdom, Neurology Devices Market 119
10.1 Medtronic Plc 119
10.1.1 Company Overview 119
10.2 B. Braun Melsungen AG 119
10.2.1 Company Overview 119
10.3 Stryker Corporation 119
10.3.1 Company Overview 119
10.4 DePuy Synthes Inc 119
10.4.1 Company Overview 119
10.5 KARL STORZ GmbH & Co KG 120
10.5.1 Company Overview 120
10.6 Integra LifeSciences Holdings Corp 120
10.6.1 Company Overview 120
10.7 Natus Medical Incorporated 120
10.7.1 Company Overview 120
10.8 Terumo Corp 120
10.8.1 Company Overview 120
10.9 St. Jude Medical LLC 121
10.9.1 Company Overview 121
10.10 LivaNova PLC 121
10.10.1 Company Overview 121
10.11 Boston Scientific Corp 121
10.11.1 Company Overview 121
10.12 Sophysa SA 121
10.12.1 Company Overview 121
11 Neurology Devices Market Pipeline Products 122
12 Financial Deals Landscape 126
12.1 Acquisition 126
12.1.1 Nestle Health Science to Acquire Phagenesis 126
12.2 Equity Offerings 127
12.2.1 Belluscura Raises USD0.7 Million in Second Tranche of Private Placement 127
12.3 Partnerships 128
12.3.1 York Instruments Enters into Agreement with eemagine Medical Imaging Solutions 128
12.3.2 GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 129
12.4 Venture Financing 131
12.4.1 Cerus Endovascular Raises USD2.4 Million in Venture Financing 131
13 Recent Developments 132
13.1 Corporate Communications 132
13.1.1 Jun 19, 2017: GSK confirms start date for Luke Miels 132
13.1.2 Jun 15, 2017: Magstim Group Appoints Lothar Krinke as New CEO 132
13.1.3 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 132
13.1.4 May 24, 2017: Kamada Presents Updated Data from Phase 2 Clinical Trial of Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency at 2017 American Thoracic Society International Conference 132
13.1.5 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer 134
13.1.6 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 134
13.1.7 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK 134
13.1.8 Jan 19, 2017: Abbas Hussain to leave GSK 135
13.1.9 Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK 135
13.1.10 Jan 17, 2017: IXICO appoints Giulio Cerroni as Chief Executive Officer 136
13.1.11 Dec 19, 2016: GSK announces Board changes 136
13.1.12 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester 137
13.1.13 Oct 14, 2016: AorTech International Announces Board Changes 137
13.1.14 Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare 138
13.1.15 Sep 20, 2016: Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline 138
13.1.16 Sep 16, 2016: IXICO: Board Changes 138
13.1.17 Sep 16, 2016: Guy's and St Thomas' NHS Foundation Trust: New Non-Executive Director appointed 139
13.1.18 Aug 09, 2016: Guy's and St Thomas' appoints Chief Operating Officer 140
13.1.19 Aug 05, 2016: Two new Non-Executive Directors join the Board of Directors 140
13.1.20 Aug 01, 2016: LivaNova Names Chief Operating Officer 141
13.1.21 Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors 141
13.1.22 Jul 27, 2016: BTG Announces Appointment of Non-executive Director 142
13.1.23 Jul 07, 2016: GSK and Save the Children call for developing country innovations to enter $1 million award 142
13.2 Financial Announcements 143
13.2.1 May 22, 2017: IXICO: Half Yearly Report to 31 March 2017 143
13.2.2 May 03, 2017: Casmed Reports First-Quarter 2017 Financial Results 143
13.2.3 May 03, 2017: LivaNova Reports First Quarter 2017 Results 144
13.2.4 Apr 26, 2017: GSK delivers another quarter of continued progress 145
13.2.5 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 148
13.2.6 Mar 29, 2017: Cambridge Cognition Holdings: Preliminary Results for the year ended 31 December 2016 148
13.2.7 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 148
13.2.8 Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016 150
13.2.9 Dec 21, 2016: AorTech International: Unaudited Interim Results For the six months ended 30 September 2016 164
13.2.10 Nov 15, 2016: BTG: Interim results 165
13.2.11 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results 166
13.2.12 Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016 167
13.2.13 Sep 29, 2016: LivaNova Announces Half-Year Financial Report 171
13.2.14 Sep 22, 2016: Cambridge Cognition Holdings: Half Yearly Report 178
13.2.15 Aug 15, 2016: AorTech International: Audited results for the year ended 31 March 2016 179
13.2.16 Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results 181
13.2.17 Jul 27, 2016: GlaxoSmithKline: Results announcement for the second quarter 2016 and half-yearly financial report for the half-year 2016 182
13.3 Government and Public Interest 196
13.3.1 Dec 02, 2016: Improving Alzheimer's Disease Research with Digital Health Technology 196
13.3.2 Sep 28, 2016: New Clinical Study on NeuroEyeCoach Conclusively Supports Meaningful Improvement in Eye Movement Efficiency 196
13.4 Legal And Regulatory 197
13.4.1 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 197
13.4.2 Dec 21, 2016: AorTech Shares Dive As Losses And Lawsuit Against Former CEO Continue 198
13.5 Other Significant Developments 198
13.5.1 Jun 07, 2017: Cambridge Cognition Holdings: Speech recognition for clinical trials 198
13.5.2 Apr 11, 2017: Stroke patients in England set to receive revolutionary new treatment 199
13.5.3 Dec 13, 2016: Magstim announces new distribution partnership in Netherlands 200
13.5.4 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 200
13.5.5 Oct 06, 2016: BTG: close period update 201
13.5.6 Sep 29, 2016: University of Glasgow to share in £17.7 million funding for new healthcare technologies research 201
13.5.7 Sep 29, 2016: Croton Healthcare Canada, York Instruments & Simon Fraser University Undertake Clinical Study Of MEG Effectiveness In Diagnosing Brain Concussions 202
13.5.8 Jul 27, 2016: GSK announces significant new investment in UK manufacturing network 203
13.5.9 Jul 14, 2016: BTG: Annual General Meeting 203
13.5.10 Jul 14, 2016: North Bristol NHS Trust wins innovation award to improve quality of health care 204
13.5.11 Jul 08, 2016: New funding for the harmonisation and alignment of brain imaging methods 205
13.6 Product News 205
13.6.1 May 18, 2017: Renishaw presents implant technology for oral and maxillofacial surgeons 205
13.6.2 Feb 23, 2017: Renishaw exhibiting at BioWales 2017 206
13.6.3 Jul 15, 2016: Alzheimer's Association International Conference 2016 206
13.7 Strategy And Business Planning 207
13.7.1 Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms 207
13.7.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 207
13.7.3 Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization 208
14 Appendix 209
14.1 Research Methodology 210
14.1.1 Coverage 210
14.1.2 Secondary Research 210
14.1.3 Primary Research 211
14.1.4 Company Share Analysis 211
14.1.5 Distribution Share Analysis 211
14.1.6 Benchmarking 212
14.2 GlobalData Consulting 212
14.3 Contact Us 213
14.4 Disclaimer 213
1.1 List of Tables
Table 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023 16
Table 2: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 18
Table 3: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 20
Table 4: Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023 22
Table 5: Neurology Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 24
Table 6: Neurology Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 26
Table 7: Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 28
Table 8: CSF Management Market, United Kingdom, Segment Contribution (%), 2016 30
Table 9: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 32
Table 10: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 34
Table 11: CSF Management Market, United Kingdom, Volume (Units), Historic, 2009-2016 36
Table 12: CSF Management Market, United Kingdom, Volume (Units), Forecast, 2016-2023 38
Table 13: CSF Management Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39
Table 14: CSF Management Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 41
Table 15: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016 44
Table 16: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 46
Table 17: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 48
Table 18: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 50
Table 19: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 52
Table 20: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 54
Table 21: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 56
Table 22: Interventional Neurology Market, United Kingdom, Volume (Units), Historic, 2009-2016 58
Table 23: Interventional Neurology Market, United Kingdom, Volume (Units), Forecast, 2016-2023 60
Table 24: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 62
Table 25: Navigational System Market, United Kingdom, Volume (Units), Historic, 2009-2016 64
Table 26: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 66
Table 27: Navigational System Market, United Kingdom, Volume (Units), Forecast, 2016-2023 68
Table 28: Interventional Neurology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 69
Table 29: Interventional Neurology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 71
Table 30: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016 73
Table 31: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 75
Table 32: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 77
Table 33: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Historic, 2009-2016 79
Table 34: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Forecast, 2016-2023 81
Table 35: Neurological Diagnostic Equipment Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 82
Table 36: Neurological Diagnostic Equipment Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 84
Table 37: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016 86
Table 38: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 88
Table 39: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 90
Table 40: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 92
Table 41: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 94
Table 42: Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 95
Table 43: Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 97
Table 44: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016 99
Table 45: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 101
Table 46: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 103
Table 47: Neurosurgical Products Market, United Kingdom, Volume (Units), Historic, 2009-2016 105
Table 48: Neurosurgical Products Market, United Kingdom, Volume (Units), Forecast, 2016-2023 107
Table 49: Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 108
Table 50: Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 110
Table 51: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 112
Table 52: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 114
Table 53: Radiosurgery Market, United Kingdom, Volume (Units), Historic, 2009-2016 116
Table 54: Radiosurgery Market, United Kingdom, Volume (Units), Forecast, 2016-2023 118
Table 55: Neurology Devices Market Pipeline Products 122
Table 56: Nestle Health Science to Acquire Phagenesis 126
Table 57: Belluscura Raises USD0.7 Million in Second Tranche of Private Placement 127
Table 58: York Instruments Enters into Agreement with eemagine Medical Imaging Solutions 128
Table 59: GlaxoSmithKline to Form Joint Venture with Verily Life Sciences 129
Table 60: Cerus Endovascular Raises USD2.4 Million in Venture Financing 131
1.2 List of Figures
Figure 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023 15
Figure 2: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 17
Figure 3: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Figure 4: Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023 21
Figure 5: Neurology Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 23
Figure 6: Neurology Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 25
Figure 7: Neurology Devices Market, United Kingdom, Company Share (%) 2016 27
Figure 8: CSF Management Market, United Kingdom, Revenue Mix ($m), 2016 29
Figure 9: CSF Management Market, United Kingdom, Segment Contribution (%), 2016 30
Figure 10: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 31
Figure 11: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 33
Figure 12: CSF Management Market, United Kingdom, Volume (Units), Historic, 2009-2016 35
Figure 13: CSF Management Market, United Kingdom, Volume (Units), Forecast, 2016-2023 37
Figure 14: CSF Management Market, United Kingdom, Company Share (%) 2016 40
Figure 15: Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2016 42
Figure 16: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016 43
Figure 17: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 45
Figure 18: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 47
Figure 19: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 49
Figure 20: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 51
Figure 21: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 53
Figure 22: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 55
Figure 23: Interventional Neurology Market, United Kingdom, Volume (Units), Historic, 2009-2016 57
Figure 24: Interventional Neurology Market, United Kingdom, Volume (Units), Forecast, 2016-2023 59
Figure 25: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 61
Figure 26: Navigational System Market, United Kingdom, Volume (Units), Historic, 2009-2016 63
Figure 27: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 65
Figure 28: Navigational System Market, United Kingdom, Volume (Units), Forecast, 2016-2023 67
Figure 29: Interventional Neurology Market, United Kingdom, Company Share (%) 2016 70
Figure 30: Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2016 72
Figure 31: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016 73
Figure 32: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 74
Figure 33: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 76
Figure 34: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Historic, 2009-2016 78
Figure 35: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Forecast, 2016-2023 80
Figure 36: Neurological Diagnostic Equipment Market, United Kingdom, Company Share (%) 2016 83
Figure 37: Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2016 85
Figure 38: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016 86
Figure 39: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 87
Figure 40: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 89
Figure 41: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 91
Figure 42: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 93
Figure 43: Neurostimulation Devices Market, United Kingdom, Company Share (%) 2016 96
Figure 44: Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2016 98
Figure 45: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016 99
Figure 46: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 100
Figure 47: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 102
Figure 48: Neurosurgical Products Market, United Kingdom, Volume (Units), Historic, 2009-2016 104
Figure 49: Neurosurgical Products Market, United Kingdom, Volume (Units), Forecast, 2016-2023 106
Figure 50: Neurosurgical Products Market, United Kingdom, Company Share (%) 2016 109
Figure 51: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 111
Figure 52: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 113
Figure 53: Radiosurgery Market, United Kingdom, Volume (Units), Historic, 2009-2016 115
Figure 54: Radiosurgery Market, United Kingdom, Volume (Units), Forecast, 2016-2023 117
